Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818972 · ClinicalTrials.gov registry record · NA
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
A NA study of Aortic Aneurysm, Thoracic and Penetrating Ulcer, sponsored by Bolton Medical.
- Active
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 20
- Study locations
NCT02818972 is a NA study of Aortic Aneurysm, Thoracic and Penetrating Ulcer that is active but no longer recruiting, run by Bolton Medical. The registered enrollment target is 110 participants, below the 218-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (50% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT02818972, a NA study of Aortic Aneurysm, Thoracic and Penetrating Ulcer, is active but no longer recruiting, sponsored by Bolton Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 20
- Study locations
Study Summary
Investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with thoracic aortic aneurysms (TAA) and penetrating atherosclerotic ulcers (PAU) of the descending thoracic aorta.
Conditions Studied
Interventions
- DEVICE RelayPro
Study Locations (20)
Massachusetts
- Tufts Medical Center - Boston
- Beth Israel Deaconess Medical Center / Harvard Medical School - Boston
- Baystate Medical Center - Springfield
California
- University of California, Irvine - Irvine
- Long Beach Memorial Hospital - Long Beach
Indiana
- Indiana University Health - Indianapolis
- St. Vincent Heart Center - Indianapolis
Ohio
- University Hospitals - Cleveland
- Cleveland Clinic Foundation - Cleveland
Pennsylvania
- University of Pennsylvania Medical Center / Penn Presbyterian - Philadelphia
- Lankenau Medical Center - Wynnewood
Alabama
- University of Alabama-Birmingham - Birmingham
Arizona
- Arizona Heart Institute - Phoenix
Connecticut
- Hartford Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02818972
The ClinicalTrials.gov registry entry for NCT02818972 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (50% lower). The listed sponsor is Bolton Medical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aortic Aneurysm, Thoracic appearing as the primary indexed condition, and to 1 intervention - of which RelayPro is the first listed.
NCT02818972 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Massachusetts, California, Indiana.
Frequently Asked Questions
What is clinical trial NCT02818972 about?
NCT02818972 is a clinical study titled "RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers". Investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with thoracic aortic aneurysms (TAA) and penetrating atherosclerotic ulcers (PAU) of the descending thoracic aorta.
What is the current status of trial NCT02818972?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2017-05-10. Estimated completion is 2025-12.
What conditions does trial NCT02818972 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Thoracic, Penetrating Ulcer.
What interventions are being tested in trial NCT02818972?
The interventions under investigation include: RelayPro (DEVICE).
Who is sponsoring clinical trial NCT02818972?
This trial is sponsored by Bolton Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02818972 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm, Thoracic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
RECRUITING · NA
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
ACTIVE NOT RECRUITING · NA
-
GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.